Cargando…

Pre-injury polypharmacy as a predictor of outcomes in trauma patients

BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, David C, Gerlach, Anthony T, Christy, Jonathan M, Jarvis, Amy M, Lindsey, David E, Whitmill, Melissa L, Eiferman, Daniel, Murphy, Claire V, Cook, Charles H, Beery, Paul R, Steinberg, Steven M, Stawicki, Stanislaw PA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249840/
https://www.ncbi.nlm.nih.gov/pubmed/22229132
http://dx.doi.org/10.4103/2229-5151.84793
_version_ 1782220394333208576
author Evans, David C
Gerlach, Anthony T
Christy, Jonathan M
Jarvis, Amy M
Lindsey, David E
Whitmill, Melissa L
Eiferman, Daniel
Murphy, Claire V
Cook, Charles H
Beery, Paul R
Steinberg, Steven M
Stawicki, Stanislaw PA
author_facet Evans, David C
Gerlach, Anthony T
Christy, Jonathan M
Jarvis, Amy M
Lindsey, David E
Whitmill, Melissa L
Eiferman, Daniel
Murphy, Claire V
Cook, Charles H
Beery, Paul R
Steinberg, Steven M
Stawicki, Stanislaw PA
author_sort Evans, David C
collection PubMed
description BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact of polypharmacy on outcomes in trauma patients 45 years and older. MATERIALS AND METHODS: Patients of age ≥45 years were identified from a Level I trauma center institutional registry. Detailed review of patient records included the following variables: Home medications, comorbid conditions, injury severity score (ISS), Glasgow coma scale (GCS), morbidity, mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, functional outcome measures (FOM), and discharge destination. Polypharmacy was defined by the number of medications: 0–4 (minor), 5–9 (major), or ≥10 (severe). Age- and ISS-adjusted analysis of variance and multivariate analyses were performed for these groups. Comorbidity–polypharmacy score (CPS) was defined as the number of pre-admission medications plus comorbidities. Statistical significance was set at alpha = 0.05. RESULTS: A total of 323 patients were examined (mean age 62.3 years, 56.1% males, median ISS 9). Study patients were using an average of 4.74 pre-injury medications, with the number of medications per patient increasing from 3.39 for the 45–54 years age group to 5.68 for the 75+ year age group. Age- and ISS-adjusted mortality was similar in the three polypharmacy groups. In multivariate analysis only age and ISS were independently predictive of mortality. Increasing polypharmacy was associated with more comorbidities, lower arrival GCS, more complications, and lower FOM scores for self-feeding and expression-communication. In addition, hospital and ICU LOS were longer for patients with severe polypharmacy. Multivariate analysis shows age, female gender, total number of injuries, number of complications, and CPS are independently associated with discharge to a facility (all, P < 0.02). CONCLUSION: Over 40% of trauma patients 45 years and older were receiving 5 or more medications at the time of their injury. Although these patients do not appear to have higher mortality, they are at increased risk for complications, lower functional outcomes, and longer hospital and intensive care stays. CPS may be useful when quantifying the severity of associated comorbid conditions in the context of traumatic injury and warrants further investigation.
format Online
Article
Text
id pubmed-3249840
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32498402012-01-06 Pre-injury polypharmacy as a predictor of outcomes in trauma patients Evans, David C Gerlach, Anthony T Christy, Jonathan M Jarvis, Amy M Lindsey, David E Whitmill, Melissa L Eiferman, Daniel Murphy, Claire V Cook, Charles H Beery, Paul R Steinberg, Steven M Stawicki, Stanislaw PA Int J Crit Illn Inj Sci Original Article BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact of polypharmacy on outcomes in trauma patients 45 years and older. MATERIALS AND METHODS: Patients of age ≥45 years were identified from a Level I trauma center institutional registry. Detailed review of patient records included the following variables: Home medications, comorbid conditions, injury severity score (ISS), Glasgow coma scale (GCS), morbidity, mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, functional outcome measures (FOM), and discharge destination. Polypharmacy was defined by the number of medications: 0–4 (minor), 5–9 (major), or ≥10 (severe). Age- and ISS-adjusted analysis of variance and multivariate analyses were performed for these groups. Comorbidity–polypharmacy score (CPS) was defined as the number of pre-admission medications plus comorbidities. Statistical significance was set at alpha = 0.05. RESULTS: A total of 323 patients were examined (mean age 62.3 years, 56.1% males, median ISS 9). Study patients were using an average of 4.74 pre-injury medications, with the number of medications per patient increasing from 3.39 for the 45–54 years age group to 5.68 for the 75+ year age group. Age- and ISS-adjusted mortality was similar in the three polypharmacy groups. In multivariate analysis only age and ISS were independently predictive of mortality. Increasing polypharmacy was associated with more comorbidities, lower arrival GCS, more complications, and lower FOM scores for self-feeding and expression-communication. In addition, hospital and ICU LOS were longer for patients with severe polypharmacy. Multivariate analysis shows age, female gender, total number of injuries, number of complications, and CPS are independently associated with discharge to a facility (all, P < 0.02). CONCLUSION: Over 40% of trauma patients 45 years and older were receiving 5 or more medications at the time of their injury. Although these patients do not appear to have higher mortality, they are at increased risk for complications, lower functional outcomes, and longer hospital and intensive care stays. CPS may be useful when quantifying the severity of associated comorbid conditions in the context of traumatic injury and warrants further investigation. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3249840/ /pubmed/22229132 http://dx.doi.org/10.4103/2229-5151.84793 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Evans, David C
Gerlach, Anthony T
Christy, Jonathan M
Jarvis, Amy M
Lindsey, David E
Whitmill, Melissa L
Eiferman, Daniel
Murphy, Claire V
Cook, Charles H
Beery, Paul R
Steinberg, Steven M
Stawicki, Stanislaw PA
Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title_full Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title_fullStr Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title_full_unstemmed Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title_short Pre-injury polypharmacy as a predictor of outcomes in trauma patients
title_sort pre-injury polypharmacy as a predictor of outcomes in trauma patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249840/
https://www.ncbi.nlm.nih.gov/pubmed/22229132
http://dx.doi.org/10.4103/2229-5151.84793
work_keys_str_mv AT evansdavidc preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT gerlachanthonyt preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT christyjonathanm preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT jarvisamym preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT lindseydavide preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT whitmillmelissal preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT eifermandaniel preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT murphyclairev preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT cookcharlesh preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT beerypaulr preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT steinbergstevenm preinjurypolypharmacyasapredictorofoutcomesintraumapatients
AT stawickistanislawpa preinjurypolypharmacyasapredictorofoutcomesintraumapatients